F2 and deep vein thrombosis: Genetic factors account for approximately 60% of deep vein thrombosis (DVT) cases, with notable thrombophilia defects, including mutations in the MTHFR gene, the factor V Leiden (G1691A) mutation, and the prothrombin G20210A mutation (19).